Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

International Stem Cell Corporation

ISCOOTCEQUITYCurrent

Quarterly Report

Filed May 14, 2026Accepted May 14, 2026, 4:00 PM EDTCIK 1355790Accession 0001193125-26-223926
Share

Company context

Current securities

Recent company filings

  1. 4 filingSep 17, 2026
  2. Completion of Acquisition or Disposition of AssetsSep 8, 2026
  3. 10-Q filingAug 13, 2026
  4. DEF 14C filingAug 4, 2026
  5. PRE 14C filingJul 24, 2026

As-filed source

Primary evidence